MD Medical Group announces CANCELLATION OF LISTING on LSE

22 June 2023 MD Medical Group Investments Plc (MD Medical Group, MDMG, the Group or the Company MOEX: MDMG), a leading Russian private healthcare provider, further to the announcement made on 23 May 2023[1], today announces that following its applications submitted to the UK Financial Conduct Authority (the FCA) and the London Stock Exchange (the LSE), the Companys global depositary receipts (the GDRs) (ISIN US55279C2008 and ISIN US55279C1018) were cancelled from the FCAs official list and admission to trading on the LSE with effect from 8:00 a.m. (London time) on 22 June 2023.

Trading in Companys GDRs will continue on the regulated market of Moscow Exchange. The rights of GDR holders under this security remain unchanged.

***

For further information please contact:

Investors

Battalova Renata

Investor Relations Director

Tel.: +7 917 294 28 82

r.battalova@mcclinics.ru

About MD Medical Group

MD Medical Group is a leading provider in the Russian private healthcare service market. The Company manages 53 modern healthcare facilities, including 10 hospitals and 43 out-patient clinics in 26 regions of Russia. In 2022, MD Medical Group's revenue amounted to RUB 25.2 bln while EBITDA amounted to RUB 7.9 bln. The Company's GDRs are traded on Moscow Exchange (MOEX: MDMG).

[1] Press release Intention to delist GDRs from the LSE published on 23 May 2023